Horyn Oksana, Luhovyy Bohdan, Lazarow Adam, Daikhin Yevgeny, Nissim Ilana, Yudkoff Marc, Nissim Itzhak
Children's Hospital of Philadelphia, Division of Child Development and Rehabilitation Medicine, Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Biochem J. 2005 Jun 1;388(Pt 2):419-25. doi: 10.1042/BJ20041260.
An important but unresolved question is whether mammalian mitochondria metabolize arginine to agmatine by the ADC (arginine decarboxylase) reaction. 15N-labelled arginine was used as a precursor to address this question and to determine the flux through the ADC reaction in isolated mitochondria obtained from rat liver. In addition, liver perfusion system was used to examine a possible action of insulin, glucagon or cAMP on a flux through the ADC reaction. In mitochondria and liver perfusion, 15N-labelled agmatine was generated from external 15N-labelled arginine. The production of 15N-labelled agmatine was time- and dose-dependent. The time-course of [U-15N4]agmatine formation from 2 mM [U-15N4]arginine was best fitted to a one-phase exponential curve with a production rate of approx. 29 pmol x min(-1) x (mg of protein)(-1). Experiments with an increasing concentration (0- 40 mM) of [guanidino-15N2]arginine showed a Michaelis constant Km for arginine of 46 mM and a Vmax of 3.7 nmol x min(-1) x (mg of protein)(-1) for flux through the ADC reaction. Experiments with broken mitochondria showed little changes in Vmax or Km values, suggesting that mitochondrial arginine uptake had little effect on the observed Vmax or Km values. Experiments with liver perfusion demonstrated that over 95% of the effluent agmatine was derived from perfusate [guanidino-15N2]arginine regardless of the experimental condition. However, the output of 15N-labelled agmatine (nmol x min(-1) x g(-1)) increased by approx. 2-fold (P<0.05) in perfusions with cAMP. The findings of the present study provide compelling evidence that mitochondrial ADC is present in the rat liver, and suggest that cAMP may stimulate flux through this pathway.
一个重要但尚未解决的问题是,哺乳动物的线粒体是否通过精氨酸脱羧酶(ADC)反应将精氨酸代谢为胍丁胺。使用15N标记的精氨酸作为前体来解决这个问题,并确定从大鼠肝脏分离得到的线粒体中通过ADC反应的通量。此外,利用肝脏灌注系统来研究胰岛素、胰高血糖素或环磷酸腺苷(cAMP)对通过ADC反应的通量可能产生的作用。在分离的线粒体和肝脏灌注实验中,外部15N标记的精氨酸生成了15N标记的胍丁胺。15N标记胍丁胺的生成具有时间和剂量依赖性。由2 mM [U-15N4]精氨酸生成[U-15N4]胍丁胺的时间进程最符合单相指数曲线,生成速率约为29 pmol·min-1·(mg蛋白质)-1。用浓度递增(0 - 40 mM)的[胍基-15N2]精氨酸进行的实验表明,精氨酸的米氏常数Km为46 mM,通过ADC反应的通量的最大反应速度Vmax为3.7 nmol·min-1·(mg蛋白质)-1。破碎线粒体的实验表明,Vmax或Km值变化不大,这表明线粒体对精氨酸的摄取对观察到的Vmax或Km值影响很小。肝脏灌注实验表明,无论实验条件如何,流出液中超过95%的胍丁胺都来源于灌注液中的[胍基-15N2]精氨酸。然而,在cAMP灌注实验中,15N标记胍丁胺的输出量(nmol·min-1·g-1)增加了约2倍(P<0.05)。本研究结果提供了令人信服的证据,证明大鼠肝脏中存在线粒体ADC,并表明cAMP可能刺激该途径的通量。